US Patent

US12458634 — Stabilized liquid formations containing picosulfate

Formulation · Assigned to Ferring BV · Expires 2038-01-27 · 12y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects stabilized liquid oral formulations containing sodium picosulfate, magnesium citrate, citric acid, malic acid, and an antioxidant.

USPTO Abstract

Oral liquid formulations are provided containing sodium picosulfate, magnesium citrate, citric acid, malic acid, and an antioxidant selected from potassium metabisulfite and sodium metabisulfite, wherein the antioxidant is present in the composition at a concentration of from about 0.002 M to about 0.1 M, and wherein the composition has a pH of from about 4.0 to about 6.5.

Drugs covered by this patent

Patent Metadata

Patent number
US12458634
Jurisdiction
US
Classification
Formulation
Expires
2038-01-27
Drug substance claim
No
Drug product claim
Yes
Assignee
Ferring BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.